- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on METASTATIC NON-SMALL CELL LUNG CANCER in Japan
Total 407 results
-
Masahiro TsuboiEli Lilly and Company; Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer Stage II | Non-small Cell Lung Cancer Stage IB | Non-small Cell Lung Cancer Stage ⅢAJapan
-
Eli Lilly and CompanyCompletedNon-small Cell Lung Cancer MetastaticJapan
-
Kyowa Kirin Co., Ltd.TerminatedNon-small-cell Lung CancerJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknownNon Small Cell Lung CancerJapan
-
Tomoshi TsuchiyaCompleted
-
Hamamatsu UniversityCompletedNon-small Cell Lung CancerJapan
-
Tokyo UniversityShionogi; National Cancer Center Hospital East; Hokkaido University; Fukushima... and other collaboratorsUnknownNon-small- Cell Lung CancerJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknownNon Small Cell Lung CancerJapan
-
National Hospital Organization Nagoya Medical CenterMerck Sharp & Dohme LLC; Central Japan Lung Study GroupActive, not recruitingNon-squamous Non-small-cell Lung Cancer | Cancer, LungJapan
-
TakedaRecruitingNon-small Cell Lung Cancer (NSCLC)Japan
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon-small Cell Lung CancerJapan
-
Shiga UniversityTokyo UniversityCompletedNon-small Cell Lung CancerJapan
-
Shiga UniversityTokyo UniversityCompletedNon-small Cell Lung CancerJapan
-
Merck Sharp & Dohme LLCActive, not recruiting
-
Shiga UniversityCompletedNon-small Cell Lung CancerJapan
-
Kyowa Kirin Co., Ltd.CompletedNon-small-cell Lung CancerJapan
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Kobe City General HospitalTerminatedAdvanced Non-small Cell Lung CancerJapan
-
Novartis PharmaceuticalsCompleted
-
R-PharmCompletedNon-small Cell Lung Cancer (NSCLC)Japan
-
Kyowa Kirin Co., Ltd.CompletedAdvanced/Recurrent Non-small-cell Lung CancerJapan
-
Kyowa Kirin Co., Ltd.Completed
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon Small Cell Lung CancerJapan
-
AstraZenecaCompletedNon-Small Cell Lung Cancer | Advanced Solid Malignancies | Neoplasms, | Metastatic Cancer,Japan
-
Genentech, Inc.Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerPoland, Belgium, Spain, United States, Canada, South Africa, Russian Federation, Hong Kong, Taiwan, Japan, France, United Kingdom, Australia, Germany, Hungary, Korea, Republic of, Netherlands, Croatia, Serbia, Israel, Ukraine, Peru, Brazi... and more
-
Eisai Co., Ltd.CompletedNon-small-cell Lung CancerJapan
-
Taiho Oncology, Inc.CompletedAdvanced or Metastatic Non-small Cell Lung CancerUnited States, France, Poland, Spain, Italy, Japan
-
ArriVent BioPharma, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer (NSCLC) | HER2 Exon 20 Mutations | EGFR Exon 20 Mutations | EGFR Uncommon Mutations, Including G719X and S768IUnited States, Australia, Spain, United Kingdom, France, Italy, China, Korea, Republic of, Canada, Japan, Netherlands
-
Astellas Pharma Global Development, Inc.Terminated
-
Daiichi Sankyo Co., Ltd.TerminatedNon Small Cell Lung CancerJapan
-
Daiichi SankyoDaiichi Sankyo Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer Metastatic | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorUnited States, Spain, Korea, Republic of, France, United Kingdom, Taiwan, Australia, Japan, China, Netherlands, Italy, Germany, Austria, Belgium, Bulgaria, Singapore
-
Astellas Pharma IncTerminatedNon-small Cell Lung CancerJapan, Korea, Republic of, Taiwan
-
ArriVent BioPharma, Inc.Allist Pharmaceuticals, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | EGFR Exon 20 MutationsUnited States, Australia, Spain, France, Italy, China, Japan, Korea, Republic of, Malaysia, Netherlands, Philippines, Singapore, Taiwan, Thailand, Brazil, Israel, United Kingdom
-
Kyoto UniversityTranslational Research Center for Medical Innovation, Kobe, Hyogo, JapanUnknown
-
Eli Lilly and CompanyActive, not recruitingMetastatic Non-Small Cell Lung CancerFrance, Spain, United States, Italy, Canada, Taiwan, Hong Kong, Japan, Turkey, Korea, Republic of, United Kingdom, Germany, Romania, Greece
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Non-Small Cell Lung CancerPoland, United States, Argentina, Austria, Brazil, Chile, China, Colombia, France, Germany, Israel, Japan, Korea, Republic of, Mexico, Spain, Taiwan, Thailand, Turkey, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Non-small Cell Lung CancerPoland, China, United States, Argentina, Brazil, Chile, France, Guatemala, Hungary, Japan, Romania, South Africa, Spain, Taiwan, Thailand, Turkey
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerJapan
-
AstraZenecaRecruitingMetastatic Non-small Cell Lung CancerSpain, Italy, Australia, United Kingdom, Korea, Republic of, Belgium, Canada, Germany, Argentina, United States, Brazil, India, Japan, France, Taiwan, Thailand, Turkey, Mexico, Hungary, China, Poland, Austria, South Africa, Czechia, Slo... and more
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon-Small Cell Lung CancerJapan
-
Hamamatsu UniversityCompletedNon-Small Cell Lung CancerJapan
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaRecruitingMetastatic Non Small Cell Lung CancerUnited States, China, Belgium, Portugal, Japan, Taiwan, France, United Kingdom, Spain, Hungary, Thailand, Germany, Italy, Switzerland, Hong Kong, Korea, Republic of, Australia, Mexico, Brazil, Netherlands, Romania, Argentina, Chile, G... and more
-
Juntendo UniversityMerck Sharp & Dohme LLCActive, not recruitingNon-squamous Non-small-cell Lung Cancer | EGFR Activating MutationJapan
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerJapan
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaRecruitingMetastatic Non Small Cell Lung CancerBelgium, Australia, United States, Korea, Republic of, Spain, China, France, Germany, Thailand, Brazil, Japan, Hong Kong, Austria, Greece, Switzerland, Netherlands, Romania, Hungary, Italy, Chile, Taiwan, Poland, Canada, Argentina, Turkey
-
PfizerRecruitingLocally Advanced or Metastatic ER+ HER2- Breast Cancer | Locally Advanced or Metastatic Castration-resistant Prostate Cancer | Locally Advanced or Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Korea, Republic of, Japan
-
Eli Lilly and CompanyCompletedColorectal Cancer | Metastatic Melanoma | Advanced Cancer | Metastatic Non-small Cell Lung CancerUnited States, Japan, Australia, France
-
TakedaActive, not recruitingAdvanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)United States, Spain, France, Korea, Republic of, Hong Kong, Australia, Taiwan, United Kingdom, Canada, Turkey, Italy, China, Germany, Japan, Austria, Belgium, Greece, Israel, Netherlands, Portugal, Russian Federation, Singapore, Sw... and more